Fondation ARC pour la recherche sur le cancer in the news

Two young researchers in Toulouse won Fondation ARC's 2025 Kerner Prize for making cancer research accessible, focusing on metabolism's role in leukemia treatment resistance and fat cells' impact on tumor growth.

A Lyon-based researcher received a prize from Fondation ARC, with full article access requiring subscription.

A solidarity concert in Le Portel on November 2 will raise funds for cancer research through Fondation ARC.

Grân’Energic raised 464 euros for cancer research by encouraging members to wear pink during sports classes and donating 1 euro per participant to Fondation ARC.

Marseille is a leading center for pancreatic cancer research, with Fondation ARC funding key projects to develop new treatments and early detection methods.

The Fondation ARC will award its 2024 Young Talents prizes to promising cancer researchers at its October event in Paris, with applications due by June 3.

Farmers in Brinon sur Beuvron support cancer awareness and donate to Fondation ARC by using colored plastic wraps on hay bales.

Cancer patients face significantly higher rates of mental health issues, and Fondation ARC provides resources to help them recognize and manage psychological distress.

Isaure Douat studies the protein periostin in aggressive triple-negative breast cancer to find new therapeutic targets, supported by Fondation ARC.

Eric Solary highlights recent breast cancer research advances, early detection, and improved treatments in a weekly TV program.

Cancer patients face significantly higher rates of mental health issues, impacting treatment and quality of life, prompting Fondation ARC to provide supportive resources.

Fondation ARC is launching a 2025 research call to study the unique biological and psychosocial aspects of cancers in adolescents and young adults aged 15-29.

Fondation ARC is recruiting top oncology researchers from the USA to establish teams in France by 2026, supporting those impacted by current US research challenges.

Mental health is an essential and often overlooked part of cancer care, with support available throughout the treatment journey.

The Oberling-Haguenau Foundation under ARC awards an annual €150,000 prize to cancer researchers for significant advances in oncology.

Professor Peter Carmeliet won the Fondation ARC prize for his pioneering work on VEGF-related anti-angiogenic cancer treatments and new therapies targeting PIGF.

The Oberling-Haguenau Thesis Prize rewards recent cancer research PhD graduates in France with high-impact publications and strong academic career plans.

The webinar discusses five years of progress and future challenges in cancer immunotherapy, featuring Fondation ARC and leading researchers.